Day One Biopharmaceuticals, Inc.DAWNNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank100
5Y CAGR+40.5%
Year-over-Year Change
Year-over-year operating income growth rate
5Y CAGR
+40.5%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
5.5x
Strong expansion
Streak
4 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 41.20% |
| 2024 | -5.44% |
| 2023 | -40.27% |
| 2022 | -101.96% |
| 2021 | -427.81% |
| 2020 | 7.53% |
| 2019 | 0.00% |